Cho Esther
SEC insider (Form 3/4/5 filer). CIK 0002081460. Chief Legal Officer at Keros Therapeutics, Inc. (KROS). 4 reported Form 4/5 transactions since Sep 2024; latest on Aug 18, 2026. Located in LEXINGTON, MA.
Companies Cho Esther has filed insider reports for
- Keros Therapeutics, Inc. (KROS): Officer, Chief Legal Officer
Cho Esther
CIK: 0002081460
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Keros Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Aug 18, 2026KROS
Keros Therapeutics, Inc.
SaleDirect4.5K shares at avg. $10.29$46K - Feb 24, 2026KROS
Keros Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
80K shares- - Feb 24, 2026KROS
Keros Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
80K shares- - Feb 18, 2026KROS
Keros Therapeutics, Inc.
SaleDirect4.7K shares at avg. $16.35$78K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 18, 2026 | KROS Keros Therapeutics, Inc. | Sale | 4,485 | $10.29 | $46,151 | Direct |
| Feb 24, 2026 | KROS Keros Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 80,000 | - | - | Direct |
| Feb 24, 2026 | KROS Keros Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 80,000 | - | - | Direct |
| Feb 18, 2026 | KROS Keros Therapeutics, Inc. | Sale | 4,745 | $16.35 | $77,581 | Direct |
1-4 of 4 transactions